Loading...
A phase 3 multicenter open-label maintenance study to investigate the long-term safety of sodium zirconium cyclosilicate in Japanese subjects with hyperkalemia
BACKGROUND: Hyperkalemia is associated with many chronic diseases and renin-angiotensin-aldosterone system inhibitor therapy. Sodium zirconium cyclosilicate (SZC), an oral, highly selective cation-exchanger, is approved for the treatment of hyperkalemia. METHODS: This phase 3, multicenter, open-labe...
Na minha lista:
| Udgivet i: | Clin Exp Nephrol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer Singapore
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7880936/ https://ncbi.nlm.nih.gov/pubmed/33098526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10157-020-01972-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|